Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ABT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ABT

Champion - 10+ consecutive years of dividend increases

Max Ratio

4.58

5Y Dividend Growth

72.00 %

Consecutive Years

11 years

5Y Average Payout Ratio

48.33 %
Forward Annual Dividend Yield 1.77 %
Consecutive Years 11
Forward Annual Dividend 2.36 USD
Consistent Years 11
Dividend CAGR 3Y 6.92 %
Continuous Dividends
Dividend CAGR 5Y 11.44 %
Payout Ratio TTM 48.54 %
Dividend CAGR 10Y 9.60 %
Ex Dividend Date 15.07.2025

Abbott Laboratories

ABT
Current price
133.60 USD -0.13 USD (-0.10%)
Last closed 133.36 USD
ISIN US0028241000
Sector Healthcare
Industry Medical Devices
Exchange NYSE
Capitalization 232 025 276 416 USD
Yield for 12 month +28.24 %
1Y
3Y
5Y
10Y
15Y
ABT
21.11.2021 - 28.11.2021

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

141.32 USD

P/E Ratio

17.32

Dividend Yield

1.77 %

Financials ABT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ABT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+41 950 000 000 USD

Last Year

+40 109 000 000 USD

Current Quarter

+10 358 000 000 USD

Last Quarter

+10 974 000 000 USD

Current Year

+23 244 000 000 USD

Last Year

+22 134 000 000 USD

Current Quarter

+5 890 000 000 USD

Last Quarter

+6 032 000 000 USD
EBITDA 11 020 999 680 USD
Operating Margin TTM 18.09 %
Price to Earnings 17.32
Return On Assets TTM 6.38 %
PEG Ratio 4.17
Return On Equity TTM 30.65 %
Wall Street Target Price 141.32 USD
Revenue TTM 42 344 001 536 USD
Book Value 28.06 USD
Revenue Per Share TTM
Dividend Share 2.28 USD
Quarterly Revenue Growth YOY 4.00 %
Dividend Yield 1.77 %
Gross Profit TTM 23 708 000 256 USD
Earnings per share 7.69 USD
Diluted Eps TTM 7.69 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 8.60 %
Profit Margin 31.89 %

Stock Valuation ABT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 17.32
Forward PE 25.84
Enterprise Value Revenue 5.62
Price Sales TTM 5.48
Enterprise Value EBITDA 21.51
Price Book MRQ 4.75

Technical Indicators ABT

For 52 Weeks

98.26 USD 140.58 USD
50 Day MA 133.39 USD
Shares Short Prior Month 22 256 461
200 Day MA 124.60 USD
Short Ratio 3.54
Shares Short 20 799 869
Short Percent 1.20 %